Added | Availability | Since | Mwt | logP | Download |
---|---|---|---|---|---|
2005-11-15 | In-Stock | 2015-08-07 | 327.424 | 2.806 |
|
Mol Formula | Rings | Heavy Atoms | Hetero Atoms | Fraction sp3 | Tranche |
---|---|---|---|---|---|
C20H25NO3 | 2 | 24 | 4 | 0.35 | EFAB |
Available 3D Representations
pH range | Net charge |
H-bond donors |
H-bond acceptors |
tPSA Ų | Rotatable bonds |
Apolar desolvationkcal/mol |
Polar desolvationkcal/mol |
Download |
---|---|---|---|---|---|---|---|---|
Reference | 1 | 2 | 3 | 50 | 6 | 9.69 | -36.71 |
|
High pH (8.4) | 0 | 1 | 4 | 49 | 6 | 7.35 | -6.91 |
|
4 Items Total
Vendors (3 Total)
1 Items Total
Annotated Catalogs (1 Total)
Activities based on ChEMBL 20
There is no known activity for this compound.
Run SEA
SEA Predictions based on ChEMBL 20
Gene | Description | Target Class | P-Value | Max Tc |
---|---|---|---|---|
CHRM3 | Muscarinic acetylcholine receptor M3 | membrane receptor / GPCR-A | 15 | 52 |
CHRM4 | Muscarinic acetylcholine receptor M4 | membrane receptor / GPCR-A | 15 | 47 |
CHRM2 | Muscarinic acetylcholine receptor M2 | membrane receptor / GPCR-A | 17 | 40 |
AMY2 | Pancreatic alpha-amylase | enzyme / enzyme-other | 67 | 43 |
Find All
Interesting Analogs
Framework of this compound
ZINC4215639

Nothing else with this framework
Scaffold of this Compound
Substance Rings
Molecular Patterns (Warnings, etc.)
References
This substance is not reported in any publications per ChEMBL.
Clinical Trials
This substance has not been detected to have been used in any clinical trials.